Your browser doesn't support javascript.
loading
HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.
Takiuchi, Yoko; Kobayashi, Masayuki; Tada, Kohei; Iwai, Fumie; Sakurada, Maki; Hirabayashi, Shigeki; Nagata, Kayoko; Shirakawa, Kotaro; Shindo, Keisuke; Yasunaga, Jun-Ichirou; Murakawa, Yasuhiro; Rajapakse, Vinodh; Pommier, Yves; Matsuoka, Masao; Takaori-Kondo, Akifumi.
Afiliação
  • Takiuchi Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Kobayashi M; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan. mkobayas@kuhp.kyoto-u.ac.jp.
  • Tada K; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Iwai F; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Sakurada M; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Hirabayashi S; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Nagata K; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Shirakawa K; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Shindo K; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Yasunaga JI; Laboratory of Virus Control, Institute for Frontier Life and Medical Sciences, Kyoto University, 53 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Murakawa Y; RIKEN Preventive Medicine and Diagnosis Innovation Program, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.
  • Rajapakse V; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 5068, Bethesda, MD, 20892-4255, USA.
  • Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 5068, Bethesda, MD, 20892-4255, USA.
  • Matsuoka M; Department of Hematology, Rheumatology and Infectious Disease, Kumamoto University Graduate School of Medicine, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Takaori-Kondo A; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto, 606-8507, Japan.
Sci Rep ; 7(1): 12849, 2017 10 09.
Article em En | MEDLINE | ID: mdl-28993637
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Leucemia-Linfoma de Células T do Adulto / Proteínas dos Retroviridae / Diester Fosfórico Hidrolases / Fatores de Transcrição de Zíper de Leucina Básica / Fator 1 Nuclear Respiratório Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Leucemia-Linfoma de Células T do Adulto / Proteínas dos Retroviridae / Diester Fosfórico Hidrolases / Fatores de Transcrição de Zíper de Leucina Básica / Fator 1 Nuclear Respiratório Idioma: En Ano de publicação: 2017 Tipo de documento: Article